Sponsored by:
Background/Introduction: Dr. Amanda Legge graduated from PCO at Salus University in 2012. She obtained an advanced studies in retina certification during her studies at PCO with additional coursework and retina-centric internships. Her retina interests include Age-related Macular Degeneration, inherited retinal disease, and diabetic and hypertensive retinopathy. She is on
ForeseeHome is cleared for patients who have BCVA of 20/60 or better and intermediate dry AMD diagnosis code.Patients with Medicare Part B and a secondary supplement plan could have as low as $0 per monthMedicare Advantage or Commercial Insurance plans require further verification to determine monthly rate - which Notal Vision
After pathology is quantified and localized, an Alert Metamorphopsia Map is generated. This map, and all patient testing data can be found on the Eye Care Professional (ECP) Portal.This Alert triggers a contact to the prescribing physician or practice. The practice then is responsible for scheduling the patient for an urgent
Once pathology is suspected, the area is bracketed to localize and quantify pathology. When a patient clicks on the “pathological distortion,” the device’s algorithm will present stimuli of various magnitudes over the location to determine the size and shape.
When the elevation caused by CNV is larger than the artificial distortion the patient will preferentially pick this spot of true distortion.
The brief presentation ensures that cortical completion is not engaged, and that fixation is maintained during the entire presentation of each stimulus. The presentation of the signal is triggered when the patient is fixating on the center of the screen.When the stimulus is projected on an unhealthy area of the macula,
The ForeseeHome device uses a patented technology called Preferential Hyperacuity Perimetry (PHP), a psychophysical test used to identify and quantify visual abnormalities such as metamorphopsia and scotoma. Hyperacuity, or Vernier acuity, is the human ability to perceive small differences in the relative spatial localization of two objects in space.During the test,
The patient starts the test by inserting their head in the viewer. A pair of infrared sensors detects the position of the head relative to the viewer. This ensures that the test is not presented until the head is correctly positioned. The patient rotates the viewer to test each eye prescribed.
The ForeseeHome device is designed as a closed viewer for single-eye examination.A set of lenses embedded within the viewer ensures that the test is viewed as if projected from infinity, such that a patient with good distance vision sees the test in maximal focus.*Patient must have 20/60 BCVA or better in
